Price $311.13 |
Market Cap
3.43B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
46.5
|
P/B
15.36
|
P/S
4.55
|
Dividend %
-
|
|
P/CF
215.1
|
P/FCF
48.3
|
Op. Cash Flow
97.2K
|
FCF
4.1
|
|
Op. Margin
12.60%
|
Net Margin
10.00%
|
ROE
36.20%
|
ROI
32.80%
|
|
ROA
18.10%
|
EPS Growth
17.70%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $0.13 | - | - | 8.4M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $3.04 | - | - | 55M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
